Skip to main content
Home Clinical Trials

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us

See what’s new.

https://otc.duke.edu/wp-content/uploads/2025/03/rami_and_challa.png

Fellow Turned Inventor Gives Glaucoma Care an Upgrade

While Gabriel and Challa iterated on the new and improved GDD, they also tapped into Duke’s innovation ecosystem resources and connected with Duke’s Office for Translation & Commercialization (OTC), Duke’s tech transfer office.

Read More

https://otc.duke.edu/wp-content/uploads/2025/03/autm-2025-hill-visit-featured-image.png

Colleagues off the Court: Duke and UNC Champion Research and Innovation on Capitol Hill

From Google’s search to 3D printing, from MRIs to mRNA vaccines, countless products and services that make our lives better started as university born innovations from research.

Read More

https://otc.duke.edu/wp-content/uploads/2025/03/mcdonnell-baxter-award-featured.png

Donald Patrick McDonnell, PhD, Wins 2025 Baxter Prize for Entrepreneurship

Professor Donald McDonnell (PCB, SOM) is a serial inventor with multiple commercialized technologies, including FDA-approved breast cancer drug ORSERDU.

Read More

https://otc.duke.edu/wp-content/uploads/2025/03/mchutchison-featured.png

Tune Therapeutics Names John McHutchison as CEO and Chairman of the Board

New Tune CEO John McHutchison has held professorships and associate directorships at SOM and DCRI. Tune is a Duke spinout and DCP portfolio company.

Read More

https://otc.duke.edu/wp-content/uploads/2025/02/DTC-announcement-story-featured-image.png

Duke Translational Chaperones help researchers secure over $6.5M in translational funding

In their pilot year, the new team at OTC worked with Duke life sciences PIs to position their research for maximal translational impact. Who will they help next?

Read More

https://otc.duke.edu/wp-content/uploads/2025/01/vividion-tavros-acquisition.png

Vividion Therapeutics Acquires Tavros Therapeutics to Expand Functional Genomics Capabilities and Boost Drug Discovery Platform

Tavros Therapeutics was co-founded by Eoin McDonnell, graduate of the Duke University Molecular Cancer Biology PhD Program, and Associate Professor Kris Wood (Pharmacology and Cancer Biology, SOM).

Read More

https://otc.duke.edu/wp-content/uploads/2024/12/humacyte-logo-new.png

Humacyte Announces FDA Approval of SYMVESS™ (acellular tissue engineered vessel-tyod) for the Treatment of Extremity Vascular Trauma

Humacyte is a Duke University start-up out of the lab of Dr. Laura Niklason (formerly Anesthesiology, SOM), co-founded with Drs. Juliana Blum and Shannon Dahl.

Read More

https://otc.duke.edu/wp-content/uploads/2024/12/TVNZ-featured-image.png

How old are you, really? Biological aging tech from Duke inventors spotlighted on TV

Professors Terrie Moffitt and Avshalom Caspi (Psychology & Neuroscience, Trinity) are leading experts in biological aging and have invented a test that is now a commercial product.

Read More

https://otc.duke.edu/wp-content/uploads/2024/12/bigner-featured-image.png

Seeds of Hope – Duke Magazine

Dr. Darell Bigner journeys from the farm to the heights of neuro-oncology and back again

Read More

1 2 3 7